Activated naive and memory cd4+ and cd8+ subsets in different stages of hiv infection

Pathobiology

Volumn 65, Issue 2, 1997, Pages 91-99

  Ginaldia, Lia ^a   Martinisa, Massimo De ^a   D’ostilio, Annamaria ^a   Gennaro, Amina Di ^a   Marinia, Lucia ^a   Profeta, Valerio ^b   Quaglino, Dennis ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b Ser T USL   (Italy)

Author keywords

CD29; CD45RA; HIV infection; HLA DR; Lymphocyte subsets

Indexed keywords

BETA1 INTEGRIN; CD4 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; HLA DR ANTIGEN;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOMODULATION; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; MALE; MEMORY CELL; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0030927034     PISSN: 10152008     EISSN: 14230291     Source Type: Journal    
DOI: 10.1159/000164109     Document Type: Article

References (50)

1. Rantazaoui S, Beades FJ, Gilbert D, Lebas FB, Michel Y, Humbert G, Tron F: During HIV infection. CD4+ CD38+ T-cclls arc the predominant circulating CD4+ subset whose HLA-DR positivity increases with disease progression and whose Vß repertoire is similar to that of CD4+ CD38-T-cclls. Clin Immunol Immunopathol 1995:77:33.
2. Lane HC, Fauci AS: Immunologic abnormalities in the acquired immunodeficiency syndrome. Annu Rev Immunol 1985:3:477.
3. Rosentberg ZF, Fauci AS: lmntunopathogene-sisof HIV infection. FASEB J 1991:5:2382.
4. Ascher MS, Sheppard HW: AIDS as immune system activation: A model for pathogenesis. Clin Exp Immunol 1988:73:165.
5. Janossv G, Borthwick N, Lomnitzer R, Medina E, Squire SB, Phillips AN, Lipman M, Johnson M A, Lee C, Bofill M: Lymphocyte activation in HIV'-I infection. Predominant proliferative defects among CD45RO+ cells of the CD4 and CD8 lineages. AIDS 1993:7:613.
6. Bass HZ, Nishanian P, Hardy WD, Mitsuyasu RT, Esmail E, Cumberland W, Fahey GL: Immune changes in HIV-I infection: Significant correlations and differences in serum markers and lymphoid phenotypic antigens. Clin Immunol Immunopathol 1992:64:63.
7. Fahcv JL, Taylor JMG, Detels R, Hofmann B, Melmed R, Nishanian P, Giorgi JV: The prognostic value of cellular and serological markers in infection with human immunodeficiency virus type 1. N Engl J Med 1990:322:166.
8. Lcvachcr M, Hulstaert F, Tallet S, Ullery S, Pocidalo JJ, Bach BA: The significance of activation markers on CD8 lymphocytes in human immunodeficiency syndrome: Staging and prognostic value. Clin Exp Immunol 1992;90: 376.
9. Giorgi J, Detels R: T-eell subset alteration in HIV-infected homosexual men: NIAD multicenter AIDS cohort study. Clin Immunol Immunopathol 1989:52:10.
10. Rabin RL, Roederer M, Maldonado Y, Petru A, Herzenbcrg LA, Herzenberg LA: Altered representation of naive and memory CD8+ T cell subsets in HIV-infected children. J Clin Invest 1995:95:2054.
11. Centers for Disease Control. US Department of Health and Human Services: Classification system for human T-lvmphotropic virus type III lymphadcnopathy-associalcd virus infections. Ann Intern Med 1986:105:234.
12. Centers for Disease Control. 1993 Revised classification system for HIV infection and expanded surveillance ease definition lor AIDS among adolescents and adults. Morbid Mortal Weekly Rep 1992:41 (RR17): 1.
13. Barker JW: An innovative lymphocyte preparation system for flow cytometry. Ann Clin Lab Sci 1988:7:32.
14. Nicholson JKA, Browning SW, Orloff SL, McDougal JS: Inactivation of HIV-infected H9 cells in whole blood preparations by lysing/fix-ing reagents used in flow-cvtometry. J Immunol Methods 1993:160:215.
15. Laurence J: T-cell subsets in health, infectious disease, and idiopathic CD4+ T lymphocytopenia. Ann Intern Med 1993:119:55.
16. Bird AG, Watret KC: CD8 T lymphocyte subset markers and HIV infection. Clin Exp Immunol 1992:90:355.
17. Stein DS, Korvick JA, Vcrmund SH: CD4+ lymphocyte cell enumeration for prediction of clinical course of human immunodeficiency virus disease: A review. J Infect Dis 1992:165: 352.
18. Philips AN, Lee CA, Elfort J, Janossy G, Bofill M, Timms A, Kernoff PBA: Prediction of progression to AIDS by analysis of CD4 lymphocyte counts in a hemophiliac cohort. AIDS 1989:3:737.
19. Fauci AS: The human immunodeficiency virus: Infectivity and mechanism of pathogenesis. Science 1988:239:617.
20. Brinehmann JE, Vartdal F, Thorsby E: T lymphocyte subset changes in human immunodeficiency virus infection. J Acquir Immune Defic Syndr 1989:2:398.
21. Radka SF, Charron DJ, Brodsky FM: Review: Class II molecules of the major histocompatibility complex considered as differentiation markers. Hum Immunol 1986:16:390.
22. Ko HS, Fu SM, Winchester RJ, Yu DTY, Kunkel HG: La determinants on stimulated human T lymphocytes: Occurrence on mitogen-and antigen-activated T cells. J Exp Med 1979:150: 246.
23. Giorgi JV, Detels R: T-cell subset alterations in HIV-l-infectcd homosexual men: NIAID multicenter AIDS cohort study. Clin Immunol Immunopathol 1989:52:10.
24. Westby M, Manca F, Dalgleish AG: The role of host immune responses in determining the outcome of HIV infection. Immunol Today 1996: 17:120.
25. Susal C, Daniel V, Opclz G: Does AIDS emerge from a disequilibrium between two complementary groups of molecules that mimic MHC? Immunol Today 1996:17:114.
26. Gowda SD, Stein BS, Mohagheghpour N, Be-nike CJ, Engleman EG: Evidence that T cell activation is required for HIV-I entry in CD4+ lymphocytes. J Immunol 1989:142:773.
27. Helbert MR, Lage-Slehr J, Mitchison NA: Antigen presentation, loss of immunological memory and AIDS. Immunol Today 1993:14: 340.
28. Schnittman SM, Lane HC, Greenhouse J, Justement JS, Baseler M, Fauci AS: Preferential infection of CD4+ memory T cells by human immunodeficiency virus type I: Evidence for a role in the selective T cell functional defects observed in infected individuals. Proc Natl Acad Sci USA 1990:87:6058.
29. Cayota A, Vuiller F, Scotl-Algara D, Dighiero G: Preferential replication of HIV-I in memory CD4+subpopulation. Lancet 1990:336:941.
30. Schnittman SM, Greenhouse JJ, Psallidopou-los MC, Baseler M, Salzman NP, Fauci AS, Lane HC: Increasing viral burden in CD4+ T cells from patients with human immunodeficiency virus (HIV) infection reflects rapidly progressive immunosuppression and clinical disease. Ann Intent Med 1990:112:438.
31. Vanham G, Kestcns L, Penne G, Goilar C, Gigasc P, Colcbunders R, Vandenbruacne M, Goeman J, van der Groen G, Cluppcns JL: Subset markers ofCD8+ cells and their relation to enhanced cytotoxic T-ccll activity during human immunodeficiency virus infection. J Clin Immunol 1991:11:345.
32. Kundu SK, Merigan TC: Relationship of HIV-1 provirus load. CD8+CD11 + Tccllsand HIV-I envelope-specific cytotoxic T lymphocytes in HIV-infected asymptomatic patients. Immunology 1994:83:81.
33. Moss DJ, Rickinson AB, Pope JH: Long-term T cell mediated immunity to Epstcin-Barr virus in man. I. Complete regression of virus-induced transformation in cultures of seropositive donor leukocytes. Int J Cancer 1978:22: 662.
34. Kemeney DM, Noble A, Holmes BJ, Diaz-San-chez D: Immune regulation: A new role for the CD8+ Tcell. ImmunolToday 1994:15:107.
35. Reddy MM, Grieco MH: Quantitative changes in T-helper inducer (CD4+CD45RA-), T-supprcssor inducer (CD4+CD45RA+), T-sup-pressor (CD8+CDI lb+). and T-cvtotoxic (CD8+CDI lb-) subsets in human immunodeficiency virus infection. J Clin Lab Anal 1991; 5:96.
36. Pichler WJ, Wvss-Coray T: T-cells as antigen presenting cells. ImmunolToday 1994:15:312.
37. Clement LT: Isoforms of the CD45 common leukocyte antigen family: Markers for human T-cell differentiation. J Immunol 1992:12:1.
38. Gray D: Immunological memory. Annu Rev Immunol 1993;49.
39. Sohen S, Rothstein T, Tallman D, Gaudette S, Schlossman S, Morimoto C: The functional heterogeneity of CD8+ cells defined by anti-CD45RA (2H4) and antiCD29 (4B4) antibodies. Cell Immunol 1990:128:314.
40. Rabin RL, Roederer M, Maldonado Y, Petru A, Herzenberg LA, Herzenberg LA: Altered representation of naive and memory CDS T cell subsets in HIV-infected children. J Clin Invest 1995:95:2054-2060.
41. Osmond DH, Shiboski S, Bacchetti P, Winger EE, Moss AR: Immune activation markers and AIDS prognosis. AIDS 199!;5:505.
42. Buijs L, Van Der Meide P, Heeney JL: The role of CDS cells in HIV infection. Immunodeficiency 1993:5:23.
43. Mackewicz CE, Ortega HW, Levy JA: CD8+ cell anti-HIV activity correlates with clinical state of infected individual. J Clin Invest 1991: 87:1462.
44. Keslens L, Vanham G, Gigasc P: Expression of activation antigens. HLA-DR and CD38 on CD8 lymphocytes during HIV-I infection. AIDS 1992:6:793.
45. Walker CM, Moody DJ, Stites DP, Levy JA: CD8+ lymphocytccan control HIV infection in vitro by suppressing virus replication. Science 1986,234:1563.
46. Brinchmann JE, Gaudcmack G, Vartdal F: CD8+cells inhibit HIV replication in naturally infected CD4+ T cells. J Immunol 1990:144: 2961.
47. Plaegcr-Marshall S, Isacescu V, O'Rourke S, Bertolli J, Bryson YJ, Stiehm ER: T cell activation in pediatric AIDS pathogenesis: Three-color immunophenotvping. Clin Immunol Immu-nopathol 1994:71:19.
48. Prince H, Jensen E: Three-colorcytofluoromct-ric analysis of CD8 cell subsets in HIV-1 infection. I Acquir Immune Defic Syndr 1991:4: 1227.
49. Roederer MJG, Dubs MT, Anderson PA, Raju LA, Herzenberg LA, Hcrzenbcrg LA: CD8 naive T cell counts decrease progressively in HIV-infected adults. J Clin Invest 1995:95: 2061.
50. Scala E, Paganelli R, Pinter E, Fanalcs-Belasio E, Mezza rama I, D'Offizi GP, Ansotcgui IJ, Fiorilli M, Aiuti F: Stage-related changes in CD4+ subsets in HIV disease. Fundam Clin Immunol 1993;2:65.